A federal court has struck down a 12-year-old Health Resources and Services Administration policy that restricted how certain 340B hospitals could make initial drug purchases, finding that the agency ...
Indiana officials are right to scrutinize how taxpayer dollars are spent, but when it comes to the proposed elimination of the federal 340B drug discount program, the state needs to be cautious. The ...
AbbVie is spearheading a new battle in pharma’s long-running fight to reform the federal government’s 340B drug discount ...
Filing in 10th Circuit Highlights Need for Oversight of Runaway PBM and Contract Pharmacy Profiteering WASHINGTON, DC, ...
April 8 (Reuters) - AbbVie has filed a lawsuit against the U.S. government, seeking clearer guidance on patients eligible for ...
AbbVie has filed a legal challenge seeking to narrow and clarify who counts as an "eligible patient" under the federal 340B ...
A federal appeals court rejected West Virginia’s bid to reverse a lower court’s decision that temporarily blocks the state’s ...
Drug companies want to end it. This is not a partisan issue. It is a math issue. And for the patients and communities we serve, it is a survival issue.
Humira and Botox maker AbbVie is suing the Trump administration to get a clearer definition of who counts as an eligible ...
"The savings from this program support pharmacy services, emergency care, behavioral health, and care for patients who are ...
Pharmaceutical companies are spending hundreds of millions lobbying elected officials to try and persuade them to gut the ...
Tuesday’s bill gives powers to the Attorney General’s Office to further enforce state law that prohibits manufacturers from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results